FR23C1024I1 - Composition stable d'une protéine anabolique osseuse qui est un analogue de pthrp, et ses emplois - Google Patents
Composition stable d'une protéine anabolique osseuse qui est un analogue de pthrp, et ses emploisInfo
- Publication number
- FR23C1024I1 FR23C1024I1 FR23C1024C FR23C1024C FR23C1024I1 FR 23C1024 I1 FR23C1024 I1 FR 23C1024I1 FR 23C1024 C FR23C1024 C FR 23C1024C FR 23C1024 C FR23C1024 C FR 23C1024C FR 23C1024 I1 FR23C1024 I1 FR 23C1024I1
- Authority
- FR
- France
- Prior art keywords
- pthrp
- analog
- stable composition
- bone protein
- anabolic bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101150071808 PTHLH gene Proteins 0.000 title 1
- 230000001195 anabolic effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84896006P | 2006-10-03 | 2006-10-03 | |
PCT/US2007/021216 WO2008063279A2 (fr) | 2006-10-03 | 2007-10-03 | Procédé d'administration pharmacologique d'une protéine anabolique osseuse |
Publications (1)
Publication Number | Publication Date |
---|---|
FR23C1024I1 true FR23C1024I1 (fr) | 2023-07-21 |
Family
ID=39430237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR23C1024C Active FR23C1024I1 (fr) | 2006-10-03 | 2023-06-05 | Composition stable d'une protéine anabolique osseuse qui est un analogue de pthrp, et ses emplois |
Country Status (28)
Country | Link |
---|---|
US (1) | US8148333B2 (fr) |
EP (2) | EP2957278B1 (fr) |
JP (1) | JP5375611B2 (fr) |
KR (4) | KR20150020289A (fr) |
CN (2) | CN101578093B (fr) |
AU (1) | AU2007322334B2 (fr) |
BR (2) | BRPI0719821B8 (fr) |
CA (1) | CA2664734C (fr) |
CY (1) | CY1119198T1 (fr) |
DK (2) | DK2957278T3 (fr) |
ES (2) | ES2739459T3 (fr) |
FR (1) | FR23C1024I1 (fr) |
HK (1) | HK1214181A1 (fr) |
HR (1) | HRP20171217T1 (fr) |
IL (1) | IL197926A (fr) |
LT (1) | LT2957278T (fr) |
MX (1) | MX2009003569A (fr) |
NL (1) | NL301235I2 (fr) |
NO (1) | NO344885B1 (fr) |
NZ (1) | NZ576682A (fr) |
PL (1) | PL2957278T3 (fr) |
PT (2) | PT2957278T (fr) |
RS (1) | RS56164B1 (fr) |
RU (1) | RU2506070C2 (fr) |
SG (1) | SG175580A1 (fr) |
SI (1) | SI2957278T1 (fr) |
UA (1) | UA98776C2 (fr) |
WO (1) | WO2008063279A2 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2957278T (pt) | 2006-10-03 | 2017-08-23 | Ipsen Pharma Sas | Uma composição estável compreendendo pthrp e utilizações da mesma |
USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
ME02474B (fr) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Schémas thérapeutiques |
BR112013007685B1 (pt) | 2010-09-28 | 2021-11-09 | Radius Pharmaceuticals, Inc | Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto |
EP2472329B1 (fr) | 2010-12-31 | 2013-06-05 | Rohm and Haas Electronic Materials LLC | Compositions de revêtement destinées à être utilisées avec une résine photosensible |
EP2472328B1 (fr) | 2010-12-31 | 2013-06-19 | Rohm and Haas Electronic Materials LLC | Compositions de revêtement destinées à être utilisées avec une résine photosensible |
WO2012145665A2 (fr) * | 2011-04-22 | 2012-10-26 | Radius Health, Inc. | Méthode d'administration de médicament de type pth, pthrp et peptides associés |
CN108195965B (zh) | 2011-06-07 | 2021-02-23 | 旭化成制药株式会社 | 含pth肽冷冻干燥制剂的检査方法及包含该含pth肽冷冻干燥制剂的医药品的制造方法 |
AU2012345768B2 (en) * | 2011-11-30 | 2016-05-12 | Kindeva Drug Delivery L.P. | Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
IL297369B1 (en) | 2015-04-29 | 2024-02-01 | Radius Pharmaceuticals Inc | RAD for use in a method to treat mutant estrogen receptor positive breast cancer or mutant estrogen receptor positive ovarian cancer |
US20180161401A1 (en) * | 2015-07-06 | 2018-06-14 | Zheng Xin Dong | Novel Formulations of PTHrP Analogue |
JP6525376B2 (ja) | 2015-08-31 | 2019-06-05 | ローム アンド ハース エレクトロニック マテリアルズ エルエルシーRohm and Haas Electronic Materials LLC | オーバーコートされたフォトレジストと共に使用するためのコーティング組成物 |
PL3359241T3 (pl) * | 2015-10-09 | 2021-12-20 | Radius Health, Inc. | Formulacje analogów pthrp, plastry przezskórne je zawierające i ich zastosowania |
US10568937B2 (en) | 2016-04-18 | 2020-02-25 | Radius Health, Inc. | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
RU2769527C2 (ru) | 2016-06-22 | 2022-04-01 | Эллипсес Фарма Лтд | Способы лечения ar+ рака молочной железы |
BR112019011070A2 (pt) * | 2016-11-30 | 2019-10-01 | Purdue Research Foundation | regeneração óssea direcionada à fratura através da estimulação do receptor de hormônio da paratireoide |
KR102322802B1 (ko) | 2017-01-05 | 2021-11-04 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
EP3765488A1 (fr) * | 2018-03-12 | 2021-01-20 | Fresenius Kabi iPSUM S.r.l. | Procédé de fabrication d'analogue de pthrp |
US11643385B2 (en) | 2018-07-04 | 2023-05-09 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCl |
WO2021149012A1 (fr) | 2020-01-24 | 2021-07-29 | Radius Health, Inc. | Méthodes de stimulation de la croissance osseuse faisant intervenir l'abaloparatide et le denosumab |
WO2023281447A1 (fr) | 2021-07-07 | 2023-01-12 | Radius Health, Inc. | Procédés de traitement d'un événement ischémique cardiovasculaire |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977070A (en) * | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
US5821225A (en) | 1992-07-14 | 1998-10-13 | Syntex (U.S.A.) Inc. | Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp |
US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
EP0679088B1 (fr) | 1992-09-29 | 2002-07-10 | Inhale Therapeutic Systems | Liberation dans les poumons de fragments actifs d'hormone parathyroidienne |
CN1070500C (zh) | 1993-07-13 | 2001-09-05 | 森德克斯(美国)股份有限公司 | 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途 |
US7410948B2 (en) * | 1995-07-13 | 2008-08-12 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Analogs of parathyroid hormone |
US5723577A (en) | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
US5969095A (en) * | 1995-07-13 | 1999-10-19 | Biomeasure, Inc. | Analogs of parathyroid hormone |
US5955574A (en) | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
US6544949B1 (en) | 1995-07-13 | 2003-04-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Analogs of parathyroid hormone |
CN1204262A (zh) * | 1995-10-17 | 1999-01-06 | 曼海姆泊灵格股份公司 | 稳定的含甲状旁腺激素的药物给药剂型 |
TW505654B (en) * | 1996-07-30 | 2002-10-11 | Hoffmann La Roche | Synthesis of analogs of PTH and PTHrP |
US6136784A (en) * | 1997-01-08 | 2000-10-24 | Amylin Pharmaceuticals, Inc. | Amylin agonist pharmaceutical compositions containing insulin |
RS49707B (sr) | 1997-09-09 | 2007-12-31 | F.Hoffmann-La Roche Ag., | Primena polipeptidnog analoga peptida srodnog paratireoidnom hormonu i njegovih soli za proizvodnju medikamenata za lečenje preloma kostiju |
US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
ZA9811127B (en) * | 1997-12-09 | 2000-07-11 | Lilly Co Eli | Stabilized teriparatide solutions. |
SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US20050124537A1 (en) * | 2000-04-27 | 2005-06-09 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US7371721B2 (en) * | 2000-09-18 | 2008-05-13 | Sanos Bioscience A/S | Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
US7799757B2 (en) * | 2002-06-13 | 2010-09-21 | Michael Chorev | Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents |
AU2002359391A1 (en) | 2002-11-01 | 2004-07-29 | Amgen, Inc. | Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein |
TWI359026B (en) * | 2004-02-12 | 2012-03-01 | Sankyo Co | Pharmaceutical composition for the osteoclast rela |
JP2007537274A (ja) * | 2004-05-10 | 2007-12-20 | ナステック ファーマスーティカル カンパニー インク. | 副甲状腺ホルモンの粘膜送達を増強するための組成物及び方法 |
US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
PT2957278T (pt) | 2006-10-03 | 2017-08-23 | Ipsen Pharma Sas | Uma composição estável compreendendo pthrp e utilizações da mesma |
-
2007
- 2007-10-03 PT PT151765484T patent/PT2957278T/pt unknown
- 2007-10-03 WO PCT/US2007/021216 patent/WO2008063279A2/fr active Application Filing
- 2007-10-03 KR KR20147033817A patent/KR20150020289A/ko active Search and Examination
- 2007-10-03 KR KR1020187030530A patent/KR20180117738A/ko not_active Application Discontinuation
- 2007-10-03 UA UAA200904264A patent/UA98776C2/ru unknown
- 2007-10-03 DK DK15176548.4T patent/DK2957278T3/en active
- 2007-10-03 BR BRPI0719821A patent/BRPI0719821B8/pt active IP Right Grant
- 2007-10-03 EP EP15176548.4A patent/EP2957278B1/fr not_active Revoked
- 2007-10-03 SG SG2011071784A patent/SG175580A1/en unknown
- 2007-10-03 CN CN2007800370219A patent/CN101578093B/zh active Active
- 2007-10-03 CN CN201110220104.XA patent/CN102274492B/zh active Active
- 2007-10-03 PT PT07870768T patent/PT2073789T/pt unknown
- 2007-10-03 NZ NZ576682A patent/NZ576682A/xx unknown
- 2007-10-03 LT LTEP15176548.4T patent/LT2957278T/lt unknown
- 2007-10-03 ES ES07870768T patent/ES2739459T3/es active Active
- 2007-10-03 RU RU2009116531/15A patent/RU2506070C2/ru not_active IP Right Cessation
- 2007-10-03 KR KR1020097008736A patent/KR101512377B1/ko active IP Right Grant
- 2007-10-03 CA CA2664734A patent/CA2664734C/fr active Active
- 2007-10-03 ES ES15176548.4T patent/ES2637283T3/es active Active
- 2007-10-03 KR KR1020177015557A patent/KR20170067906A/ko not_active Application Discontinuation
- 2007-10-03 DK DK07870768.4T patent/DK2073789T3/da active
- 2007-10-03 US US12/311,418 patent/US8148333B2/en active Active
- 2007-10-03 EP EP07870768.4A patent/EP2073789B8/fr active Active
- 2007-10-03 RS RS20170803A patent/RS56164B1/sr unknown
- 2007-10-03 SI SI200731956T patent/SI2957278T1/sl unknown
- 2007-10-03 JP JP2009531434A patent/JP5375611B2/ja active Active
- 2007-10-03 MX MX2009003569A patent/MX2009003569A/es active IP Right Grant
- 2007-10-03 AU AU2007322334A patent/AU2007322334B2/en active Active
- 2007-10-03 PL PL15176548T patent/PL2957278T3/pl unknown
- 2007-10-03 BR BRPI0722428-1A patent/BRPI0722428A2/pt not_active Application Discontinuation
-
2009
- 2009-04-05 IL IL197926A patent/IL197926A/en active IP Right Grant
- 2009-04-20 NO NO20091545A patent/NO344885B1/no unknown
- 2009-10-02 HK HK16102423.5A patent/HK1214181A1/zh unknown
-
2017
- 2017-08-08 HR HRP20171217TT patent/HRP20171217T1/hr unknown
- 2017-08-10 CY CY20171100860T patent/CY1119198T1/el unknown
-
2023
- 2023-06-05 FR FR23C1024C patent/FR23C1024I1/fr active Active
- 2023-06-09 NL NL301235C patent/NL301235I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR23C1024I1 (fr) | Composition stable d'une protéine anabolique osseuse qui est un analogue de pthrp, et ses emplois | |
HK1096555A1 (en) | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13 | |
EP1986674A4 (fr) | Compositions protéiques ou peptidiques protéine contenant de la méthionine et leur procédé de fabrication et d'utilisation | |
BRPI0813699A2 (pt) | Formulações de proteína de fusão glp-1-fc | |
IL218357A0 (en) | Compositions and methods of using angiopoietin-like 4 protein | |
EP2182006A3 (fr) | Compositions et procédés pour le traitement de maladies liées au système immunitaire | |
EP1487488A4 (fr) | Anticorps specifiques contre un peptide beta-amyloide, compositions pharmaceutiques et methodes d'utilisation | |
EP1765379A4 (fr) | Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees | |
ATE457736T1 (de) | Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid | |
CR10863A (es) | Anticuerpos humanos contra el ligando 4 de tipo delta humano | |
PL1890720T3 (pl) | Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania | |
IL196516A0 (en) | Human endogenous retrovirus polypeptide compositions and methods of use thereof | |
IL188288A0 (en) | Polypeptide having an activity of suppressing food intake and pharmaceutical compositions containing the same | |
FR2901273B1 (fr) | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant | |
CL2007002619A1 (es) | Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion. | |
DE602006007995D1 (de) | Formulierungen von liponsäure und hyaluronsäurebeneichen | |
FR2949782B1 (fr) | Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant. | |
FR2925500B1 (fr) | Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant | |
ITMI20021684A1 (it) | Composizione farmaceutica di peptide nasale | |
FR2932680B1 (fr) | Association de tiliroside et d'un peptide | |
FR2907681B1 (fr) | Composition pharmaceutique et/ou cosmetique contenant des polypeptides ou des peptides. | |
FR2946340B1 (fr) | Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. | |
HUP0600489A2 (en) | Use of echinacea or preparations made thereof for the manufacture of pharmaceutical compositions for the treatment of anxiety | |
FR2889050B1 (fr) | Analogue d'implant dentaire | |
ZA200710374B (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |